Article
A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Feb 2017
Smit Amelia K, Espinoza David, Newson Ainsley J, Morton Rachael L, Fenton Georgina, Freeman Lucinda, Dunlop Kate, Butow Phyllis N, Law Matthew H, Kimlin Michael G, Keogh Louise A, Dobbinson Suzanne J, Kirk Judy, Kanetsky Peter A, Mann Graham J, Cust Anne E
Abstract excerpt
BACKGROUND: Communication of personalized melanoma genomic risk information may improve melanoma prevention behaviors. METHODS: We evaluated the feasibility and acceptability of communicating personalized genomic risk of melanoma to the public and its preliminary impact on behaviors and psychosocial outcomes. One hundred eighteen people aged 22 to 69 years provided a saliva sample and were randomized to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
